Literature DB >> 8889450

Screening for hepatocellular carcinoma.

G H Haydon1, P C Hayes.   

Abstract

Hepatocellular carcinoma (HCC) is a major worldwide health problem and the most common cause of cancer induced mortality. This review article examines the natural history of HCC and the known risk factors, as well as evaluating the current methods of detection of HCC and their impact on patient survival.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8889450

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN： 0954-691X            Impact factor:   2.566


  10 in total

1.  Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998.

Authors:  S D Taylor-Robinson; M B Toledano; S Arora; T J Keegan; S Hargreaves; A Beck; S A Khan; P Elliott; H C Thomas
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

2.  Value of combined detection of AFU and TCH in differential diagnosis between malignant and non-tuberculous benign ascites.

Authors:  Hong Zhang; Feng Li; Qun Wei; Yu-Fei Zhu
Journal:  Med Oncol       Date:  2010-11-02       Impact factor: 3.064

3.  Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders.

Authors:  Z W Zhu; H Friess; L Wang; M Abou-Shady; A Zimmermann; A D Lander; M Korc; J Kleeff; M W Büchler
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

4.  Recent developments in the first detection of hepatocellular carcinoma.

Authors:  Joseph B Lopez
Journal:  Clin Biochem Rev       Date:  2005-08

Review 5.  Diagnosis of hepatocellular carcinoma.

Authors:  Asmaa I Gomaa; Shahid A Khan; Edward L S Leen; Imam Waked; Simon D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

6.  Deterioration of hepatic functional reserve in patients with hepatocellular carcinoma after resection: incidence, risk factors, and association with intrahepatic tumor recurrence.

Authors:  Teh-Ia Huo; Wing-Yu Lui; Jaw-Ching Wu; Yi-Hsiang Huang; Kuang-Liang King; Che-Chuan Loong; Pui-Ching Lee; Full-Young Chang; Shou-Dong Lee
Journal:  World J Surg       Date:  2004-02-17       Impact factor: 3.352

Review 7.  An update of biochemical markers of hepatocellular carcinoma.

Authors:  Abdulaziz Ajlan M AlSalloom
Journal:  Int J Health Sci (Qassim)       Date:  2016-01

Review 8.  Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma.

Authors:  Fabio Grizzi; Barbara Franceschini; Cody Hamrick; Eldo E Frezza; Everardo Cobos; Maurizio Chiriva-Internati
Journal:  J Transl Med       Date:  2007-01-23       Impact factor: 5.531

9.  Does 18F-FDG positron emission tomography-computed tomography have a role in initial staging of hepatocellular carcinoma?

Authors:  Yuri Cho; Dong Hyeon Lee; Yun Bin Lee; Minjong Lee; Jeong-Ju Yoo; Won-Mook Choi; Young Youn Cho; Jin Chul Paeng; Keon Wook Kang; June-Key Chung; Su Jong Yu; Jeong-Hoon Lee; Jung-Hwan Yoon; Hyo-Suk Lee; Yoon Jun Kim
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

Review 10.  Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications.

Authors:  Massimiliano Berretta; Carla Cavaliere; Lara Alessandrini; Brigida Stanzione; Gaetano Facchini; Luca Balestreri; Tiziana Perin; Vincenzo Canzonieri
Journal:  Oncotarget       Date:  2017-02-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.